Craig Greven to Humans
This is a "connection" page, showing publications Craig Greven has written about Humans.
Connection Strength
0.226
-
Manning RA, Carlson JN, Hein EW, Weaver RG, Greven CM. Bilateral Candida endophthalmitis in a premature infant. J AAPOS. 2013 Apr; 17(2):206-7.
Score: 0.025
-
Greven CM, Kurup SK, Jacklin HN. Intraocular erosion and intrusion of an Arruga encircling suture. Retina. 2011 Jul-Aug; 31(7):1437-8.
Score: 0.023
-
Kurup SK, Gee C, Greven CM. Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration. Acta Ophthalmol. 2010 Jun; 88(4):e145-6.
Score: 0.020
-
Dickinson PJ, Greven CM. Avoiding and managing the dislocated crystalline lens. Compr Ophthalmol Update. 2006 May-Jun; 7(3):113-27.
Score: 0.016
-
Greven CM, Bashinsky AL. Circumstance and outcome of ocular paintball injuries. Am J Ophthalmol. 2006 Feb; 141(2):393.
Score: 0.016
-
Greven CM. Central retinal vein occlusion secondary to an intraocular nematode. Arch Ophthalmol. 2005 May; 123(5):704-5.
Score: 0.015
-
Greven CM, Piccione K. Delayed visual loss after pars plana vitrectomy for retained lens fragments. Retina. 2004 Jun; 24(3):363-7.
Score: 0.014
-
Greven CM, Collins AS, Slusher MM, Weaver RG. Visual results, prognostic indicators, and posterior segment findings following surgery for cataract/lens subluxation-dislocation secondary to ocular contusion injuries. Retina. 2002 Oct; 22(5):575-80.
Score: 0.012
-
Singer MA, Miller DM, Gross JG, Greven CM, Kapik B, Bailey C, Ghanchi F, Kuppermann BD. Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 µg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I). Ophthalmic Surg Lasers Imaging Retina. 2018 09 01; 49(9):698-706.
Score: 0.009
-
Gower EW, Lovato JF, Ambrosius WT, Chew EY, Danis RP, Davis MD, Goff DC, Greven CM. Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study. Am J Ophthalmol. 2018 03; 187:138-147.
Score: 0.009
-
Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014 Dec; 121(12):2443-51.
Score: 0.007
-
Mottl AK, Pajewski N, Fonseca V, Ismail-Beigi F, Chew E, Ambrosius WT, Greven C, Schubart U, Buse J. The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial. J Diabetes Complications. 2014 Nov-Dec; 28(6):874-9.
Score: 0.007
-
Casanova R, Saldana S, Chew EY, Danis RP, Greven CM, Ambrosius WT. Application of random forests methods to diabetic retinopathy classification analyses. PLoS One. 2014; 9(6):e98587.
Score: 0.007
-
Bressler SB, Almukhtar T, Aiello LP, Bressler NM, Ferris FL, Glassman AR, Greven CM. Green or yellow laser treatment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network. Retina. 2013 Nov-Dec; 33(10):2080-8.
Score: 0.007
-
Gangaputra S, Lovato JF, Hubbard L, Davis MD, Esser BA, Ambrosius WT, Chew EY, Greven C, Perdue LH, Wong WT, Condren A, Wilkinson CP, Agrón E, Adler S, Danis RP. Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity. Retina. 2013 Jul-Aug; 33(7):1393-9.
Score: 0.006
-
van der Vaart R, Greven C, Manning R, Haines N, Kurup SK. Unilateral solitary choroidal granuloma as presenting sign of secondary syphilis. Graefes Arch Clin Exp Ophthalmol. 2011 Oct; 249(10):1575-7.
Score: 0.006
-
Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010 Jul 15; 363(3):233-44.
Score: 0.005
-
Ambrosius WT, Danis RP, Goff DC, Greven CM, Gerstein HC, Cohen RM, Riddle MC, Miller ME, Buse JB, Bonds DE, Peterson KA, Rosenberg YD, Perdue LH, Esser BA, Seaquist LA, Felicetta JV, Chew EY. Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol. 2010 Mar; 128(3):312-8.
Score: 0.005
-
Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):844-8.
Score: 0.005
-
Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007 Oct; 114(10):1860-7.
Score: 0.004
-
Chew EY, Ambrosius WT, Howard LT, Greven CM, Johnson S, Danis RP, Davis MD, Genuth S, Domanski M. Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol. 2007 Jun 18; 99(12A):103i-111i.
Score: 0.004
-
McDonald HR, Oliveira LB, Ferreira MA, Greven CM, Kim I. Diagnostic and therapeutic challenges. Retina. 2006 Sep; 26(7):818-22.
Score: 0.004